Trial Profile
An Open-label, Single Centre, Randomised, Cross-over Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam After Repeat Dose Administration of Ulimorelin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2012
Price :
$35
*
At a glance
- Drugs Ulimorelin (Primary) ; Midazolam
- Indications Anxiety disorders; Sleep disorders
- Focus Pharmacokinetics
- Sponsors Norgine
- 02 Aug 2011 New trial record